Compugen Ltd
CGEN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001119774
In the last 90 days, Compugen Ltd insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; ARK Invest is the only superinvestor holding it.
13F holders, Q3 2021
Institutional positions in Compugen Ltd as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 108
- +2 vs. Q2 2021
- Shares held
- 35.3M
- −1.61M (−4.4%) vs. Q2 2021
- Total value
- $210.8M
- −$94.7M (−31.0%) vs. Q2 2021
- New holders
- 15
- 31 more added
- Sold out
- 13
- 34 more reduced
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CGEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 83 | $30.3M |
| Q1 2026 | 79 | $30.3M |
| Q4 2025 | 73 | $19.3M |
| Q3 2025 | 69 | $18.3M |
| Q2 2025 | 70 | $26.8M |
| Q1 2025 | 71 | $22.1M |
| Q4 2024 | 70 | $18.6M |
| Q3 2024 | 65 | $21.7M |
| Q2 2024 | 66 | $20.7M |
| Q1 2024 | 74 | $33.0M |
| Q4 2023 | 73 | $21.5M |
| Q3 2023 | 66 | $11.7M |
| Q2 2023 | 69 | $13.1M |
| Q1 2023 | 68 | $7.68M |
| Q4 2022 | 74 | $11.6M |
| Q3 2022 | 81 | $14.5M |
| Q2 2022 | 90 | $70.1M |
| Q1 2022 | 110 | $135.3M |
| Q4 2021 | 114 | $147.1M |
| Q3 2021 | 108 | $210.8M |
| Q2 2021 | 108 | $305.7M |
| Q1 2021 | 109 | $344.0M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Compugen Ltd; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Artisan Partners Limited Partnership | 802,877 | $4.79M | 0.01% | +44,732+5.9% | Added |
| Rock Springs Capital Management LP | 1,283,790 | $7.66M | 0.16% | +46,802+3.8% | Added |
| Morgan Stanley | 1,623,298 | $9.69M | 0.00% | −166,669−9.3% | Reduced |
| Vanguard Group Inc | 2,313,174 | $13.8M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 2,538,702 | $15.2M | 0.00% | +160,523+6.7% | Added |
| Nikko Asset Management Americas, Inc. | 7,027,400 | $42.0M | 0.18% | −135,006−1.9% | Reduced |
| ARK Investment Management LLCSuperinvestorARK Invest | 9,832,678 | $58.7M | 0.14% | −2,142,929−17.9% | Reduced |
| IFP Advisors, Inc | 50 | – | – | +50 | New |
| Summit Global Investments | 0 | $0 | 0.00% | −49,100−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −46,894−100.0% | Sold out |
| Eagle Global Advisors LLC | 0 | $0 | 0.00% | −39,000−100.0% | Sold out |
| Cornerstone Investment Partners, LLC | 0 | $0 | 0.00% | −19,460−100.0% | Sold out |
| Marshall Wace North America L.P. | 0 | $0 | 0.00% | −16,331−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −14,794−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −12,703−100.0% | Sold out |
| Toroso Investments, LLC | 0 | $0 | 0.00% | −12,374−100.0% | Sold out |
| Budros, Ruhlin & Roe, Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| NEXT Financial Group, Inc | 0 | $0 | 0.00% | −2,161−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −1,360−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Modus Advisors, LLC | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Pictet Asset Management Ltd | – | – | – | – | Not filed |
| CWS Financial Advisors, LLC | – | – | – | – | Not filed |